Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-17,516
Closed -$1.35M – 716
2022
Q4
$1.35M Sell
17,516
-45,370
-72% -$3.51M 0.03% 532
2022
Q3
$4.71M Buy
+62,886
New +$5.09M 0.05% 275
2021
Q1
– Sell
-45,880
Closed -$2.92M – 917
2020
Q4
$2.92M Buy
+45,880
New +$2.95M 0.06% 313
2016
Q2
– Sell
-136,710
Closed -$7.11M – 505
2016
Q1
$7.11M Buy
+136,710
New +$6.59M 0.07% 241
2015
Q3
– Sell
-127,468
Closed -$6.31M – 738
2015
Q2
$6.31M Buy
+127,468
New +$6.75M 0.05% 306
2014
Q4
– Sell
-281,300
Closed -$14.8M – 712
2014
Q3
$14.8M Sell
281,300
-8,550
-3% -$441K 0.26% 111
2014
Q2
$15.2M Sell
289,850
-217,164
-43% -$10.8M 0.1% 102
2014
Q1
$24.5M Sell
507,014
-20,986
-4% -$976K 0.46% 68
2013
Q4
$23.7M Buy
528,000
+273,000
+107% +$12.1M 0.44% 73
2013
Q3
$10.9M Buy
255,000
+80,088
+46% +$3.4M 0.23% 134
2013
Q2
$7.15M Buy
+174,912
New +$7.13M 0.13% 199

Other funds holding SRE

UBS O'Connor's SRE Position: Q1 2023 in Review

UBS O'Connor sold out of Sempra (SRE) in Q1 2023, closing a stake of 17,516 shares — an estimated $1.35M sold.

UBS O'Connor first reported a position in SRE in Q2 2013 and held it in 11 quarters. The position peaked at $24.5M in Q1 2014. 982 funds tracked by Wall St. Rank hold SRE as of Q1 2023.

  • UBS O'Connor reported no remaining Sempra position as of Q1 2023 after selling out during the quarter.
  • UBS O'Connor sold 17,516 Sempra shares in Q1 2023, an estimated $1.35M.
  • UBS O'Connor first reported a position in Sempra in Q2 2013 and held it in 11 quarters.
  • UBS O'Connor's Sempra position peaked at $24.5M in Q1 2014.
  • 982 funds tracked by Wall St. Rank held Sempra as of Q1 2023.

Based on UBS O'Connor's 13F filing for Q1 2023, filed 15 May 2023.